T32 Integrative Training in Oncogenic Signaling Postdoctoral Fellow Program

The Integrative Training in Oncogenic Signaling (ITOS) Program was developed by a select group of cancer scientists affiliated with MUSC Hollings Cancer Center, a vibrant NCI-designated cancer center. Hollings is embedded in MUSC’s active and growing biomedical academic environment with state-of-the-art research facilities.

The ITOS program will train five postdoctoral trainees each year for five years, offering outstanding research exposure, academic development, and professional opportunities. Selected fellows will utilize a wide variety of biological systems, approaches, and technologies in the study and translation of basic cellular processes involved in the development of cancer.

ITOS fellows will also have access to the most modern types of high-resolution imaging, advanced microscopy, genome-level profiling, proteomics, gene manipulation, and cell tracking, as well as exposure to systems biology and bioinformatics. Fellows will likely be supported in the program for two years.

ITOS fellows will be paired with a primary mentor and at least one secondary mentor from a pool of highly successful ITOS program faculty.

Program Goals

  • Provide proactive mentoring and oversight and research training in cutting-edge cancer research methodology.
  • Develop useful academic and essential career development skills.
  • Foster collaborative, interdisciplinary interactions with faculty and other trainees.
  • Provide exposure to current cancer research discoveries and how these are being translated into novel approaches to prevention, diagnosis, and treatment of cancer.

Program Leadership

Philip H. Howe 

Philip H. Howe, Ph.D.

Program Director

Michael Ostrowski, Ph.D. 

Michael Ostrowski, Ph.D.

Associate Program Director